DILIC
GILD icon

Dai-ichi Life Insurance Company’s Gilead Sciences GILD Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2M Sell
195,288
-13,858
-7% -$1.94M 0.78% 22
2025
Q4 		$25.7M Buy
209,146
+4,960
+2% +$603K 0.66% 30
2025
Q3 		$22.7M Buy
204,186
+16,100
+9% +$1.83M 0.57% 42
2025
Q2 		$20.9M Sell
188,086
-23,836
-11% -$2.54M 0.59% 39
2025
Q1 		$23.7M Buy
211,922
+43,775
+26% +$4.52M 0.69% 37
2024
Q4 		$15.5M Sell
168,147
-3,269
-2% -$294K 0.43% 57
2024
Q3 		$14.4M Sell
171,416
-205,601
-55% -$15.7M 0.36% 70
2024
Q2 		$25.9M Buy
377,017
+112,395
+42% +$7.5M 0.63% 38
2024
Q1 		$19.4M Sell
264,622
-64,661
-20% -$4.97M 0.44% 49
2023
Q4 		$26.7M Sell
329,283
-431,436
-57% -$33.6M 0.55% 42
2023
Q3 		$57M Buy
760,719
+404,000
+113% +$31.1M 1.26% 10
2023
Q2 		$27.5M Buy
356,719
+8,825
+3% +$704K 0.57% 36
2023
Q1 		$28.9M Buy
347,894
+37,911
+12% +$3.14M 0.63% 28
2022
Q4 		$26.6M Sell
309,983
-32,383
-9% -$2.56M 0.62% 32
2022
Q3 		$21.1M Hold
342,366
– – 0.52% 39
2022
Q2 		$21.2M Sell
342,366
-128,337
-27% -$7.95M 0.47% 45
2022
Q1 		$28M Sell
470,703
-62,339
-12% -$3.98M 0.45% 50
2021
Q4 		$38.7M Sell
533,042
-2,655
-0.5% -$183K 0.5% 37
2021
Q3 		$37.4M Sell
535,697
-81,434
-13% -$5.72M 0.49% 36
2021
Q2 		$42.5M Buy
617,131
+128,672
+26% +$8.59M 0.53% 28
2021
Q1 		$31.6M Sell
488,459
-28,960
-6% -$1.87M 0.44% 39
2020
Q4 		$30.1M Buy
517,419
+195,237
+61% +$11.8M 0.44% 42
2020
Q3 		$20.4M Buy
322,182
+52,535
+19% +$3.64M 0.37% 45
2020
Q2 		$20.7M Buy
269,647
+121,583
+82% +$9.32M 0.47% 32
2020
Q1 		$11.1M Buy
148,064
+49,286
+50% +$3.41M 0.42% 56
2019
Q4 		$6.42M Sell
98,778
-34,632
-26% -$2.26M 0.15% 156
2019
Q3 		$8.46M Sell
133,410
-3,060
-2% -$200K 0.2% 114
2019
Q2 		$9.22M Sell
136,470
-463
-0.3% -$30.5K 0.22% 107
2019
Q1 		$8.9M Sell
136,933
-869
-0.6% -$57.8K 0.22% 110
2018
Q4 		$8.62M Sell
137,802
-1,159
-0.8% -$81K 0.24% 107
2018
Q3 		$10.7M Sell
138,961
-13,503
-9% -$1.02M 0.23% 108
2018
Q2 		$10.8M Sell
152,464
-16,618
-10% -$1.17M 0.26% 97
2018
Q1 		$12.7M Buy
169,082
+12,514
+8% +$995K 0.26% 83
2017
Q4 		$11.2M Sell
156,568
-3,833
-2% -$291K 0.22% 91
2017
Q3 		$13M Buy
160,401
+376
+0.2% +$28.8K 0.28% 72
2017
Q2 		$11.3M Buy
160,025
+11,299
+8% +$752K 0.25% 80
2017
Q1 		$10.1M Sell
148,726
-58,657
-28% -$4.12M 0.27% 86
2016
Q4 		$14.9M Buy
+207,383
New +$15.4M 0.44% 55

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dai-ichi Life Insurance Company's GILD Position: Q1 2026 in Review

Dai-ichi Life Insurance Company reduced its Gilead Sciences (GILD) stake by 6.6% in Q1 2026, selling an estimated $1.94M and leaving 195,288 shares worth $27.2M. The position accounts for 0.78% of the portfolio, ranked #22.

Dai-ichi Life Insurance Company first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. The position peaked at $57M in Q3 2023. 2,314 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Dai-ichi Life Insurance Company held 195,288 shares of Gilead Sciences worth $27.2M as of Q1 2026.
  • Dai-ichi Life Insurance Company sold 13,858 Gilead Sciences shares in Q1 2026, an estimated $1.94M.
  • Gilead Sciences made up 0.78% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #22 holding.
  • Dai-ichi Life Insurance Company first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
  • Dai-ichi Life Insurance Company's Gilead Sciences position peaked at $57M in Q3 2023.
  • 2,314 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.